newsfilter
← Latest News
GlobeNewswire·

Immunovant Awarded U.S. Patent for IMVT-1402

Composition of matter patent issued with coverage until June 2043Patent also includes methods of use and methods of manufacturing claims NEW YORK, March 12, 2024 (GLOBE NEWSWIRE) -- Immunovant, Inc. (NASDAQ:IMVT), a